HGRO — Hedgeye Quality Growth ETF

Is HGRO overbought or oversold? Here is the current MarketMoodz read.

Neutral As of August 19, 2026

Hedgeye Quality Growth ETF (HGRO) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The stock last closed at $30.59. The rating moved from Overbought to Neutral on August 19, 2026.

AI analysis

Key considerations include Quality-growth investment mandate targets companies with durable revenue/profitability characteristics which can outperform in a risk-on environment, Recent market tone has tilted mildly risk-on, favoring growth-oriented and cyclically exposed strategies, ETF structure provides diversified exposure and intraday liquidity compared with single-stock exposure.

Key factors

  • Quality-growth investment mandate targets companies with durable revenue/profitability characteristics which can outperform in a risk-on environment
  • Recent market tone has tilted mildly risk-on, favoring growth-oriented and cyclically exposed strategies
  • ETF structure provides diversified exposure and intraday liquidity compared with single-stock exposure
  • Potential for inflows if macro headlines continue to calm rate concerns and support growth rotation
  • Relatively straightforward thesis versus active single-stock selection—lower idiosyncratic company risk

Risks

  • Higher-for-longer interest rates or unexpected hawkish Fed commentary could weigh on growth-oriented holdings
  • Concentration risk in style/sector exposures (growth, tech, consumer discretionary) could amplify drawdowns
  • Market volatility or a risk-off shock would likely pressure price and lead to outflows
  • Tracking error or liquidity differences in underlying holdings could widen during stressed markets
  • Limited public filing/firm-specific disclosures available in this dataset restrict granular assessment of holdings

See today's live rating, score and targets

Members see the live hourly rating for HGRO — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.